Transcranial low-level laser stimulation in the near-infrared-II region (1064 nm) for brain safety in healthy humans

BACKGROUND: The use of near-infrared lasers for transcranial photobiomodulation (tPBM) offers a non-invasive method for influencing brain activity and is beneficial for various neurological conditions. However, comprehensive quantitative studies on its safety are lacking. OBJECTIVE: This study aims to investigate the safety of 1064-nm laser-based tPBM across brain structure, brain function, neural damage, cognitive ability and tolerance. METHODS: We employed a multimodal approach, using magnetic resonance imaging (MRI), electroencephalogram (EEG), biochemical analyses, and cognitive testing to quantitatively assess the potential adverse effects of tPBM on brain structure or function, neurons, glial cells, and executive function (EF). Additionally, a detailed questionnaire was used to evaluate subjective tolerance. RESULTS: At the whole-brain structural level, no significant variations in gray matter, white matter, or cerebrospinal fluid volume or density were observed as a result of tPBM. There was no increase in neuron-specific enolase (NSE) or S100β levels suggesting no neuronal damage, but an unexpected significant reduction in NSE was detected which requires further study to assess its implications. EEG, analyzed through power spectra and expert evaluation, revealed no potential disease-inducing effects. A series of cognitive tests demonstrated no impairment in any of the EF components. Furthermore, the questionnaire data revealed minimal discomfort across fatigue, itching, pain, burning, warmth, dizziness, and drowsiness. CONCLUSIONS: Our data indicate that 1064 nm laser tPBM does not induce adverse effects on brain structure or function, nor does it impair cognitive abilities. tPBM is safe for specific parameters, highlighting its good tolerability.